Back to top
more

Fresenius Medical Care AG & Co. (FMS)

(Delayed Data from NYSE)

$21.09 USD

21.09
1,168,346

+0.91 (4.51%)

Updated Sep 13, 2024 04:00 PM ET

After-Market: $21.08 -0.01 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for FMS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Fresenius Medical Care AG & Co KGaA falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 1,783 1,342 1,753 1,235 1,129
Receivables 3,936 3,913 4,225 3,706 4,010
Notes Receivable 0 0 0 0 0
Inventories 2,359 2,419 2,411 2,165 1,863
Other Current Assets 1,340 968 1,037 1,204 1,023
Total Current Assets 9,418 8,643 9,426 8,311 8,025
Net Property & Equipment 4,094 4,375 5,010 4,634 4,693
Investments & Advances 1,358 815 931 869 781
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 307 329 373 401 405
Intangibles 17,330 18,238 18,718 16,380 17,297
Deposits & Other Assets 242 858 1,094 885 843
Total Assets 36,722 37,671 40,659 36,198 36,887
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 958 981 1,015 945 935
Current Portion Long-Term Debt 1,022 1,436 2,276 1,242 2,933
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 207 152 163 135 114
Other Current Liabilities 3,759 3,535 4,350 4,018 3,150
Total Current Liabilities 6,615 6,814 8,587 7,036 7,848
Mortgages 0 0 0 0 0
Deferred Taxes/Income 812 987 1,027 898 828
Convertible Debt 0 0 0 0 0
Long-Term Debt 7,533 7,555 7,864 7,768 7,233
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,897 1,818 1,806 1,975 1,608
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 20,675 21,393 24,120 22,112 22,072
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 318 309 347 335 341
Capital Surplus 3,659 3,554 3,421 3,281 4,041
Retained Earnings 11,821 11,286 12,808 11,714 10,589
Other Equity 250 1,129 -37 -1,244 258
Treasury Stock 0 0 0 0 415
Total Shareholder's Equity 16,047 16,277 16,539 14,086 14,815
Total Liabilities & Shareholder's Equity 36,722 37,671 40,659 36,198 36,887
Total Common Equity 16,047 16,277 16,539 14,086 14,815
Shares Outstanding 586.80 586.80 585.90 585.60 596.60
Book Value Per Share 27.35 27.74 28.23 24.05 24.83

Fiscal Year End for Fresenius Medical Care AG & Co KGaA falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 1,517 1,518 1,783 1,691 1,484
Receivables 4,375 4,397 3,936 4,043 3,976
Notes Receivable 0 0 0 0 0
Inventories 2,399 2,406 2,359 2,508 2,547
Other Current Assets 1,068 1,756 1,340 1,614 1,095
Total Current Assets 9,358 10,078 9,418 9,855 9,102
Net Property & Equipment 3,930 3,988 4,094 4,286 4,311
Investments & Advances 1,479 1,417 1,358 767 759
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 299 291 307 331 342
Intangibles 17,405 17,410 17,330 18,300 18,345
Deposits & Other Assets 142 150 242 949 925
Total Assets 36,503 37,279 36,722 38,785 38,121
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable 0 0 0 0 0
Accounts Payable 981 907 958 919 893
Current Portion Long-Term Debt 865 982 1,022 1,368 1,751
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 150 245 207 242 211
Other Current Liabilities 3,733 3,932 3,759 3,967 3,658
Total Current Liabilities 6,392 6,735 6,615 7,204 7,223
Mortgages 0 0 0 0 0
Deferred Taxes/Income 748 772 812 929 942
Convertible Debt 0 0 0 0 0
Long-Term Debt 7,381 7,618 7,533 7,907 7,630
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,880 1,897 1,807 1,890
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 20,148 20,850 20,675 21,986 21,841
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 316 319 318 319 320
Capital Surplus 3,647 3,676 3,659 3,677 3,676
Retained Earnings 11,708 11,972 11,821 11,710 11,605
Other Equity 684 463 250 1,093 679
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 16,355 16,429 16,047 16,799 16,280
Total Liabilities & Shareholder's Equity 36,503 37,279 36,722 38,785 38,121
Total Common Equity 16,355 16,429 16,047 16,799 16,280
Shares Outstanding 586.80 586.80 586.80 586.80 586.80
Book Value Per Share 27.87 28.00 27.35 28.63 27.74